<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694105</url>
  </required_header>
  <id_info>
    <org_study_id>regional block adjuvants</org_study_id>
    <nct_id>NCT04694105</nct_id>
  </id_info>
  <brief_title>Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block</brief_title>
  <official_title>Peri-neural Dexmedetomidine Versus Dexamethasone as an Adjuvant to Bupivacaine Single Injection in Ultrasoundguided Supraclavicular Brachial Plexus Block for Arteriovenous Fistula: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to assessthe impact of addition of Dexmedetomidine or Dexamethasone to Bupivacaine, on&#xD;
      Duration of analgesia (time in hours to the first report of postoperative pain )at the&#xD;
      surgical site&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, controlled double blinded study included 42 adult patients undergoing&#xD;
      arteriovenous fistula surgery. Ultrasound-guided supraclavicular brachial plexus block was&#xD;
      initiated after placement of full monitoring . Supraclavicular brachial plexus block was&#xD;
      achieved with the use of total volume 32 ml of anesthetic drugs in all patients. Bupivacaine&#xD;
      30 ml 0.25% was combined with 2 ml normal saline (control group A, n=14), Bupivacaine 30 ml&#xD;
      0.25% was combined with 50 microgram (0.5 ml) peri-neural dexmedetomidine plus 1.5 ml normal&#xD;
      saline ( dexmedetomidine group B ,n=14), or Bupivacaine 30 ml 0.25% was combined with 4 mg&#xD;
      peri neural dexamethasone (2 ml) ( dexamethasone group C, n=14).The onset and duration of&#xD;
      sensory and motor blocks, the time to first request to postoperative rescue analgesic,&#xD;
      Richmond Agitation-Sedation Score, hemodynamic data, visual analogue pain scores, were&#xD;
      reported at predetermined time assessment points. Postoperative rescue intravenous fentanyl&#xD;
      consumption over 24 hours and complications occurred were recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">January 12, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>double blind both anesthetist and patient not aware about type of local anesthesia</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>&quot;UP to 4 hours post operative&quot;</time_frame>
    <description>(time in hours to the first report of postoperative pain at the surgical site, administered of opioid when VAS score was&gt;4).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain scores.</measure>
    <time_frame>&quot;at 8 and 24 hours post operative&quot;</time_frame>
    <description>Severity of pain at the surgical site (VAS) score</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Brachial Plexus Block</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 30 ml 0.25% was combined with 50 microgram (0.5 ml) peri-neural dexmedetomidine plus 1.5 ml normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 30 ml 0.25% was combined with 4 mg peri neural dexamethasone (2 ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bupivacaine 30 ml 0.25% was combined with 2 ml normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine injection</intervention_name>
    <description>perineural injection of Bupivacaine 30 ml 0.25% combined with 50 microgram (0.5 ml) peri-neural dexmedetomidine plus 1.5 ml normal saline</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>perineural injection of Bupivacaine 30 ml 0.25% combined with 4 mg peri neural dexamethasone (2 ml)</description>
    <arm_group_label>dexamethasone</arm_group_label>
    <other_name>decadrone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>perineural injection of Bupivacaine 30 ml 0.25% combined with 2 ml normal saline</description>
    <arm_group_label>control group</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All the patients included in the study aged 18 to 60 years old were on chronic&#xD;
             hemodialysis and they had a hemodialysis session one day before the block performance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological, neuromuscular, psychiatric disorders, hepatic, respiratory, or cardiac&#xD;
             diseases; coagulation disorders; infection at the block injection site; patients with&#xD;
             a body mass index more than 35; or patients who refused the procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tarek A Radwan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr Alini Univeristy Hospital</name>
      <address>
        <city>Cairo</city>
        <state>Giza</state>
        <zip>11451</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Kulenkampff D. BRACHIAL PLEXUS ANAESTHESIA: ITS INDICATIONS, TECHNIQUE, AND DANGERS. Ann Surg. 1928 Jun;87(6):883-91.</citation>
    <PMID>17865904</PMID>
  </results_reference>
  <results_reference>
    <citation>Neal JM. Ultrasound-Guided Regional Anesthesia and Patient Safety: Update of an Evidence-Based Analysis. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):195-204. doi: 10.1097/AAP.0000000000000295.</citation>
    <PMID>26695877</PMID>
  </results_reference>
  <results_reference>
    <citation>Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, Liu H. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013 Apr 16;127(15):1576-84. doi: 10.1161/CIRCULATIONAHA.112.000936. Epub 2013 Mar 19.</citation>
    <PMID>23513068</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 4, 2021</last_update_submitted>
  <last_update_submitted_qc>January 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>mahmoud salem soliman</investigator_full_name>
    <investigator_title>Head of intensive care unit at new kaser al ainy teaching hospital , lecterur of anaesthesia and intensive care cairo universty</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>dexamethasone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

